Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 09627Y109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,367,984
Percent of class
8.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-018026
Form type
SC 13G/A
Filer
Blueprint Medicines Corp
CIK
CIK 1597264
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub